1 completed, 1 recruiting, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
Follow CAR T-Cell-Related Encephalopathy Syndrome: new trials by email Literature Review of CAR T-Cell-Related Encephalopathy Syndrome trials Research Report on CAR T-Cell-Related Encephalopathy Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia CAR T-cell therapy - Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia | Phase 1 | Recruiting | National University Hospital, Singapore | 20 | 2021-09-08 | 2021-09-14 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. CAR T-cell therapy - Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia | Phase 1 | Unknown | National University Hospital, Singapore | 40 | 2021-04-28 | 2021-09-09 |
| Multicenter Study Using IMC to Analyze the Impact of ICANS on Microglia There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion. - ICANS, Grade Unspecified, CAR T-Cell-Related Encephalopathy Syndrome | Completed | University of Freiburg | 8 | 2021-04-12 | 2023-05-16 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Leukemia (1)
National University Hospital, Singapore (2) · University of Freiburg (1)
Singapore (2) · Germany (1)
Allen Yeoh, M.D (2) · Dario Campana, M.D, PhD (2)